Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other neoplasm 2Head & Neck 2

Conditions

Precancerous Conditions 51Leukemia 13Lymphoma 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Leukemia, Lymphocytic, Chronic, B-Cell 11Multiple Myeloma 10Neoplasms, Plasma Cell 9Myelodysplastic Syndromes 9Lymphoma, Non-Hodgkin 9Lymphoma, Mantle-Cell 9Lymphoma, Large-Cell, Immunoblastic 9Lymphoma, Large B-Cell, Diffuse 9Lymphoma, Follicular 9Lymphoma, B-Cell, Marginal Zone 9Leukemia, Myeloid, Acute 9Burkitt Lymphoma 9Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8Myeloproliferative Disorders 8Monoclonal Gammopathy of Undetermined Significance 8Lymphoma, Large-Cell, Anaplastic 8Immunoblastic Lymphadenopathy 8Hodgkin Disease 8Waldenstrom Macroglobulinemia 7Lymphoma, T-Cell, Cutaneous 7Leukemia, Biphenotypic, Acute 7Uterine Cervical Dysplasia 6Primary Myelofibrosis 6Leukemia, Prolymphocytic 6Leukemia, Myelomonocytic, Chronic 6Leukemia, Myeloid, Chronic-Phase 6

Interventions

Carboplatin 2130-nm albumin-bound paclitaxel 2toripalimab 1sintilimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Salivary Gland Malignant Neoplasms × Other neoplasm × Clear all
NCT05000892 2022-12-02

Neoadjuvant Sintilimab in Combination With Carboplatin and Nab-paclitaxel in Untreated Salivary Gland Malignant Neoplasms

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 2 Recruiting
15 enrolled
Head & NeckOther neoplasm

Salivary Gland Malignant Neoplasms

NCT04825938 2021-04-28

Neoadjuvant Toripalimab in Combination With Carboplatin and Nab-paclitaxel in Untreated Salivary Gland Malignant Neoplasms

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 2 Not yet recruiting
15 enrolled
Head & NeckOther neoplasm

Salivary Gland Malignant Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡